Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 047804/0401 | |
| Pages: | 5 |
| | Recorded: | 12/18/2018 | | |
Attorney Dkt #: | PAT057341-US-PCT |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16306925
|
Filing Dt:
|
12/04/2018
|
Publication #:
|
|
Pub Dt:
|
07/25/2019
| | | | |
Title:
|
TESIDOLUMAB FOR USE IN THE TREATMENT OF TRANSPLANT REJECTION
|
|
Assignee
|
|
|
250 MASSACHUSETTS AVENUE |
CAMBRIDGE, MASSACHUSETTS 02139 |
|
Correspondence name and address
|
|
NOVARTIS PHARMACEUTICALS CORPORATION
|
|
ONE HEALTH PLAZA
|
|
BUILDING 433
|
|
EAST HANOVER, NJ 07936
|
Search Results as of:
09/24/2024 04:57 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|